Overview

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Status:
Terminated
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
Does pancreas enzyme replacement (PERT) decrease weight loss and improve quality of life in patients with unresectable pancreatic cancer?
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massimo Raimondo, M.D.
Collaborator:
Digestive Care, Inc.
Treatments:
Pancreatin
Pancrelipase